3-Morpholino-1-phenyl-1-propanone

Product Overview & Core Commercial Positioning

3-Morpholino-1-phenyl-1-propanone serves as a critical Mannich base pharmaceutical intermediate and a core precursor for synthesizing muscle relaxants and CNS drugs such as Tolperisone. The specific arrangement of functional groups within its molecular structure endows it with exceptional synthetic reactivity. Within high-end pharmaceutical supply chains, this product is not only a critical enabler for ensuring downstream drug efficacy but also a strategic material choice for pharmaceutical companies tackling complex synthesis challenges and achieving high-purity output.

Product Specifications

Industry Pain Points & Our Process Advantages

In the pharmaceutical intermediate industry, traditional production methods for such products often face severe challenges regarding thermodynamic thermal decomposition. Conventional batch processes, due to the mismatch between heat transfer efficiency and reaction kinetics, are prone to inducing side reactions that result in dark-colored products and high tar residue. This not only significantly increases decolorization and solvent costs in downstream API production but may also cause poisoning and failure of expensive precious metal catalysts due to trace impurities. Furthermore, inadequate control of halogen residues in traditional processes often becomes a compliance pain point for enterprises during quality audits.

Our process pathway precisely resolves these challenges through controlled ultra-fast thermal history and coupled physical phase separation technology. By managing residence time at the microsecond level, we achieve immediate reaction termination within the optimal reaction window for target product generation, ensuring the product exhibits extremely high transmittance and minimal initial impurity content. Simultaneously, we employ a full-process halogen-free catalytic scheme, eliminating the risk of halogen damage to downstream catalytic systems at the source. This high-purity, low-color, wash-free grade material assists downstream clients in significantly shortening purification cycles and extending catalyst lifespan, achieving significant cost reduction and efficiency improvement while ensuring supply chain robustness.

Source Factory & Proprietary Continuous Flow Technology Advantages

Ningbo Inno Pharmchem Co., Ltd. (NINGBO INNO PHARMCHEM CO.,LTD.), as a source manufacturer, possesses self-developed and self-designed tubular continuous flow reaction equipment. Leveraging excellent batch stability and an inherently safe production system, we are committed to providing customers with high-quality chemicals. We explicitly express our willingness to establish long-term strategic partnerships with trading companies and end-users, jointly promoting the upgrade and development of the pharmaceutical chemical supply chain.